Akero Therapeutics Inc (AKRO)
20.43
+0.25 +1.24%
NASDAQ
Dec 2, 16:00
20.40
-0.02 -0.12%
After-Hours: 20:00
USD
Akero Therapeutics Market Cap:
712.77M for Dec. 2, 2021View 4,000+ financial data types
Browse...
View Full Chart
Market Cap Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Historical Market Cap Data
View and export this data going back to 2019.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| Dec. 2, 2021 | 712.77M |
| Dec. 1, 2021 | 704.05M |
| Nov. 30, 2021 | 741.73M |
| Nov. 29, 2021 | 730.56M |
| Nov. 26, 2021 | 737.19M |
| Nov. 24, 2021 | 773.82M |
| Nov. 23, 2021 | 844.99M |
| Nov. 22, 2021 | 834.53M |
| Nov. 19, 2021 | 866.28M |
| Nov. 18, 2021 | 906.75M |
| Nov. 17, 2021 | 888.60M |
| Nov. 16, 2021 | 873.25M |
| Nov. 15, 2021 | 904.65M |
| Nov. 12, 2021 | 883.72M |
| Nov. 11, 2021 | 865.23M |
| Nov. 10, 2021 | 844.65M |
| Nov. 9, 2021 | 899.07M |
| Nov. 8, 2021 | 894.90M |
| Nov. 5, 2021 | 915.13M |
| Nov. 4, 2021 | 894.90M |
| Nov. 3, 2021 | 850.96M |
| Nov. 2, 2021 | 789.58M |
| Nov. 1, 2021 | 803.53M |
| Oct. 29, 2021 | 749.47M |
| Oct. 28, 2021 | 770.05M |
| Oct. 27, 2021 | 754.00M |
| Oct. 26, 2021 | 751.91M |
| Oct. 25, 2021 | 750.52M |
| Oct. 22, 2021 | 740.05M |
| Oct. 21, 2021 | 730.29M |
| Oct. 20, 2021 | 723.66M |
| Oct. 19, 2021 | 748.08M |
| Oct. 18, 2021 | 748.42M |
| Oct. 15, 2021 | 744.24M |
| Oct. 14, 2021 | 770.05M |
| Oct. 13, 2021 | 769.00M |
| Oct. 12, 2021 | 764.82M |
| Oct. 11, 2021 | 755.75M |
| Oct. 8, 2021 | 736.57M |
| Oct. 7, 2021 | 739.01M |
| Oct. 6, 2021 | 754.00M |
| Oct. 5, 2021 | 751.21M |
| Oct. 4, 2021 | 746.33M |
| Oct. 1, 2021 | 773.19M |
| Sept. 30, 2021 | 779.46M |
| Sept. 29, 2021 | 779.16M |
| Sept. 28, 2021 | 803.92M |
| Sept. 27, 2021 | 838.08M |
| Sept. 24, 2021 | 827.27M |
| Sept. 23, 2021 | 840.87M |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
Advertisement
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 21.12M |
| Palatin Technologies Inc | 128.28M |
| iBio Inc | 159.09M |
Market Cap Range, Past 5 Years
| Minimum | 366.18M | Mar 18 2020 |
| Maximum | 1.321B | Jul 27 2020 |
| Average | 826.70M |
Market Cap Related Metrics
| Price to Book Value | 3.588 |
| Price | 20.43 |
| Earnings Yield | -13.80% |
News
--Morgan Stanley Adjusts Akero Therapeutics' Price Target to $29 from $27, Keeps Equalweight Rating
MT Newswires 11/15 10:11 ET
MT Newswires 11/15 10:11 ET
HC Wainwright Adjusts Price Target on Akero Therapeutics to $62 from $64, Keeps Buy Rating
MT Newswires 11/15 10:10 ET
MT Newswires 11/15 10:10 ET
--Canaccord Genuity Adjusts Price Target on Akero Therapeutics to $49 From $46, Keeps Buy Rating
MT Newswires 11/15 09:23 ET
MT Newswires 11/15 09:23 ET
Akero Therapeutics to Present at the Jefferies London Healthcare Conference
Globe Newswire 11/09 16:15 ET
Globe Newswire 11/09 16:15 ET
Akero Gets FDA Fast-Track Label for Efruxifermin for Liver Inflammation Treatment; Shares Up After Hours
MT Newswires 10/19 16:38 ET
MT Newswires 10/19 16:38 ET
Akero Therapeutics Receives FDA Fast Track Designation for Efruxifermin (EFX) for the Treatment of NASH
Globe Newswire 10/19 16:15 ET
Globe Newswire 10/19 16:15 ET
Advertisement
